QA: SOLIGENIX INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000812796_2023_SOLIGENIX_INC.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000812796, SOLIGENIX INC.

  xvar xval
0 AssetsCurrent 13,853,152
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 18,481
3 remainder_Assets 408,084
4 LiabilitiesCurrent 16,516,873
5 LiabilitiesNoncurrent 233,627
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 550,822
8 SellingGeneralAndAdministrativeExpense 6,692,904
9 ResearchAndDevelopmentExpense 7,944,089
10 remainder_Expenses -1,154,935
11 remainder_Revenues 948,911
12 remainder_NetIncome -714,370
13 remainder_ComprehensiveNetIncome -17,195
  yvar yval
0 Assets 14,279,717
1 Liabilities 16,750,500
2 Expenses 14,032,880
3 Revenues 948,911
4 StockholdersEquity -2,470,783
5 NetIncome -13,798,339
6 ComprehensiveNetIncome -13,806,936
7 BaseVar 23,371,786
8 EconomicCapitalRatio -1.16

Edgar->Model Mapping

Feature Distribution

Change over Time